oxycodone drugs market, oxycodone drugs market size, oxycodone drugs market share, oxycodone drugs market growth, oxycodone drugs market report, global oxycodone drugs market
What is the present valuation and projected CAGR of the oxycodone drugs market?
The oxycodone drugs market size has grown strongly in recent years. It will grow from $5.62 billion in 2024 to $6.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to an aggressive marketing campaign for oxycontin, the drug was marketed for chronic non-malignant pain and cancer, the number of oxycontin prescriptions for non-cancer-related pain increased the demand for these drugs and after the second world war, synthetic opiates like oxycodone began to enter the market in greater numbers.
The oxycodone drugs market size is expected to see strong growth in the next few years. It will grow to $7.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to the increasing prevalence of chronic pain, rising number of surgical procedures, ongoing development in the products pipeline is expected to boost the growth, advancements in drug delivery systems and a rising aging population worldwide experiencing a higher incidence of chronic pain. Major trends in the forecast period include increased demand for abuse-deterrent formulations (ADFS), the development of novel delivery systems, the growing use of combination therapies, and technological advancements in manufacturing.
Get Your Free Sample of The Global Oxycodone Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp
Which Market drivers have played a significant role in driving the oxycodone drugs market?
The high burden of orthopedic disorders is expected to propel the growth of the oxycodone drug market going forward. Orthopedic disorders refer to a range of musculoskeletal conditions, including bones, joints, ligaments, tendons, and muscles, leading to pain, impaired mobility, and functional limitations. The rising incidence of orthopedic disorders is due to aging populations, sedentary lifestyles, obesity, sports injuries, and occupational hazards. Oxycodone drugs are utilized in orthopedic disorders to alleviate acute and chronic pain resulting from conditions such as fractures, joint injuries, or post-surgical discomfort, providing effective relief by acting on the central nervous system’s pain receptors. For instance, in October 2023, according to the Institute for Health Metrics and Evaluation, a US-based research institute, the projected cases of musculoskeletal disorders (orthopedic disorders) are anticipated to rise by 115% (with a range of 107–124%) from 2020 to 2050, reaching an estimated 1,060 million prevalent cases by 2050. Therefore, the high burden of orthopedic disorders is driving the growth of the oxycodone drug market.
What are the key segments within the oxycodone drugs market?
The oxycodone drugs market covered in this report is segmented –
1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Short Acting Oxycodone: ImMedia & Entertainmentte-Release Oxycodone Tablets, Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report
Which key players are shaping the oxycodone drugs market?
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences
Which transformative trends will shape the oxycodone drugs market landscape?
Major companies operating in the oxycodone drug market are focusing their efforts on developing innovative drugs, such as oxycodone imMedia & Entertainmentte-release (IR) tablets, to reduce drug abuse via injection and the intranasal route. Oxycodone imMedia & Entertainmentte-release (IR) tablets are a formulation of the opioid analgesic medication oxycodone that is designed to provide rapid pain relief. For instance, in July 2022, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, launched RoxyBond (oxycodone) imMedia & Entertainmentte-release (IR) tablets in the United States. RoxyBond has been authorized by the U.S. Food and Drug Administration (FDA) as an opioid agonist for the treatment of severe pain, necessitating an opioid analgesic when other options are insufficient. It is engineered with advanced technology to deter misuse and abuse, rendering it difficult to tamper with physically or chemically.
How do regional factors impact the oxycodone drugs market, and which region is the largest contributor?
North America was the largest region in the oxycodone drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Oxycodone Drugs Market Report 2025 Offer?
The oxycodone drugs market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Oxycodone drug is a potent opioid analgesic medication used primarily for the management of moderate to severe pain. It belongs to the class of drugs known as opioid agonists, which act on specific receptors in the brain and spinal cord to alter the perception of pain. Oxycodone drug is an effective pain management option when used appropriately and under the supervision of a healthcare provider.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15886
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
